The involvement of systemic factors in COVID-19 pathophysiology begins with the initial infection and entry point to cells in the lung epithelium via the Angiotensin converting enzyme-2 (ACE2) membrane-bound carboxypeptidase. The gene discussed is ACE2; the disease is infection.